Finn
HCA Healthcare Services · Hospitals · ACA exposure · Medicaid payments · Thesis updated July 27, 2026

Medicaid approval masks a sharp jump in uninsured patients

01 Running thesis

Medicaid payments offset a messy mix

HCA is dealing with a sharp divergence between regulatory headwinds and tailwinds. The negative impact from the expiration of enhanced ACA subsidies is materializing worse than management initially modeled. Patients losing exchange coverage are migrating almost one-for-one to uninsured status, rather than finding employer coverage. This drove a revision of the full-year EBITDA headwind to $1 billion to $1.2 billion.

At the same time, the company secured approval for the Florida Medicaid supplemental payment program. This provided a $540 million incremental net benefit and raised full-year program guidance to $300 million to $500 million. This tailwind is largely masking the pain from the exchange shift.

The bull case is that this Medicaid payment cushion gives HCA enough room to handle the ACA exchange pressure while its internal financial resiliency programs hold costs flat. If the current drop in elective surgeries is just a cyclical macro bump, HCA can return to its normal growth rates once the ACA losses finalize.

The bear case centers on underlying medical demand. In Q2 2026, elective inpatient surgeries fell 6% and outpatient surgeries fell 3.4%. If this weakness extends beyond the people losing ACA coverage, or if the uninsured shift keeps growing faster than state Medicaid payments can offset, the core profit engine will slow down.

Jul 2026Q2 2026 results showed a worse-than-feared hit from ACA exchanges and weak elective surgery volumes, offset by a major benefit from a new Florida Medicaid program.
Apr 2026The Q1 2026 Form 10-Q confirmed the main call takeaways. Surgery volumes were weak, uninsured admissions rose, and risk factors had no material change.
Apr 2026Q1 guidance held, but the mix changed. Better state supplemental payments offset a mild respiratory season, storms, and the expected ACA exchange hit.
Feb 2026The 2025 Form 10-K confirmed strong 2025 growth and the key 2026 risks. It also showed Medicaid state directed and supplemental payment revenue rose to about $6.2 billion in 2025.
Jan 2026Initial 2026 guidance set clear headwinds: $600 million to $900 million from ACA exchanges and a $250 million to $450 million decline in state supplemental payment benefits. Management also set a $400 million resiliency savings target.
Oct 2025The Q3 2025 Form 10-Q confirmed the stronger Q3 view and did not add new material risk factors. The main forward risk stayed the possible ACA subsidy expiration.
Oct 2025Q3 2025 was stronger than expected, and HCA raised adjusted EBITDA guidance by $450 million at the midpoint. Surgery volumes also returned to growth in the quarter.
Jul 2025Q2 2025 results improved after Tennessee's state directed payment program was approved. Full-year 2025 guidance moved higher, though management trimmed volume growth expectations.
02 Business model

Hospitals with local scale

HCA makes money by treating patients in hospitals, emergency rooms, surgery centers, and other outpatient sites. Patients pay through commercial insurance, Medicare, Medicaid, ACA exchange plans, or self-pay. The company does not collect full list prices in most cases. It gets paid based on contracts, government rules, and patient ability to pay.

The strategy is to build deep networks in attractive markets. HCA adds beds, outpatient sites, doctors, and high-acuity programs so a patient can stay inside the HCA system for many needs. Scale matters because HCA can spread technology, staffing systems, purchasing, billing, and clinical processes across many facilities.

The model breaks when payer mix worsens. If more patients move from ACA exchange plans to uninsured status, HCA may still treat them but collect less cash. That risk is now a reality. Management noted a one-for-one shift to uninsured status in Q2 2026, which heavily hit three Southern divisions.

Capital needs are also large. HCA planned 2026 capital spending of $5.0 billion to $5.5 billion, and it had over $46 billion of debt at the end of 2025. That does not make the model broken, but it means weak earnings or higher rates can matter faster.

03 Product portfolio

Care lines that drive the system

Cash cow

Inpatient hospital care

This is the core of HCA. Admissions, bed use, and case mix drive a large part of revenue and profit.

Steady

Emergency rooms

ERs bring patients into the network and often feed admissions.

Option

Outpatient surgery

Outpatient care is important because more procedures keep moving outside the hospital. The problem is current softness, with same-facility outpatient surgery down 3.4% in Q2 2026.

Growth engine

High-acuity services

Cardiac, trauma, transplant, and neonatal programs help HCA treat harder cases. These services can raise case mix, which means more revenue per patient.

Steady

Medicaid supplemental payment programs

These programs are not a medical service, but they are a major payment source. A new Florida approval brought a massive cash cushion in Q2 2026.

04 Business segments

One system, two revenue settings

Inpatient and admitted care patient revenue62%modest
Outpatient patient revenue38%flat

HCA reports as one hospital system, not as many business segments. The mix below uses 2025 patient revenue settings from the 2025 Form 10-K: outpatient revenue was 38% of patient revenue, so inpatient and related admitted care was the balance.

05 Risk factors

What could break the thesis

ACA exchange drop gets worse

High impact · High odds

The ACA exchange headwind has intensified materially. Management revised the full-year expected EBITDA impact to negative $1 billion to $1.2 billion. Three divisions account for about 50% of this impact.

We watchTotal full-year EBITDA impact from exchange changes and ACA attrition rates.

Uninsured mix keeps rising

High impact · High odds

HCA treats many patients even when they cannot pay much. Uninsured volumes are growing significantly, driven mostly by a one-for-one migration of patients losing ACA exchange coverage rather than finding employer plans.

We watchUninsured equivalent admissions and total uncompensated care cost.

Surgery weakness is not temporary

High impact · Medium odds

Surgery is a clear watch item because it can carry strong economics. Same-facility outpatient surgery fell 3.4% in Q2 2026, and inpatient elective surgery fell 6%. If this continues, the core growth picture is softer than the Medicaid payments make it look.

We watchQ3 and Q4 same-facility inpatient and outpatient elective surgery growth.

State payment help fades

High impact · Medium odds

Medicaid state directed and supplemental payments are a major offset right now. The Florida program provided a large boost in Q2 2026, but these programs remain political and subject to CMS review and renewal.

We watchCMS decisions on state directed payment programs and proposed Medicaid work requirements.
06 Quick answers

In one breath

How does HCA Healthcare make money?

HCA gets paid for hospital care, emergency visits, surgery, and outpatient services. Payment comes from commercial insurance, Medicare, Medicaid, ACA exchange plans, and patients who pay on their own.

Why are ACA exchanges important for HCA?

Exchange plans cover patients who might otherwise be uninsured. When patients lose this coverage, they often migrate to uninsured status, which creates a large headwind to profits.

What is the biggest upside catalyst for HCA?

A stabilization in elective surgical volumes would show that medical demand is healthy. Continued cost savings from internal resiliency programs would also help margins.

Is HCA a low-risk healthcare stock?

No. HCA has scale and strong market positions, but it also has high exposure to government payment rules, uninsured volume, labor costs, and debt.

Get started with Finn today